EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

TIMP1 and CLDN23 may contribute to adenoma-to-colorectal cancer progression and nominate ruxolitinib for repurposing

Penghang Lin, Chunlin Lin, Yuexin Lin, Songyi Liu, Fangqiu Ruan, Yan Lin, Shuyuan Zhang, Zhixiong Liu, Weilong Li, Jie Li, Jianxin Ye, Guangwei Zhu

Translational Oncology · 2027-01 · 75 · 103116

DOI: 10.1016/j.tranon.2026.103116 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Translational Oncology, 2027-01. Verfasst von Penghang Lin und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery II, The First Affiliated Hospital of Fujian Medical University, Fuzhou, 350005, China; Department of Gastroint…. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

CLDN23Colorectal cancerRuxolitinibSingle-cell transcriptomicsTIMP1

Autor:innen und Institutionen

  • Department of Gastrointestinal Surgery II, The First Affiliated Hospital of Fujian Medical University, Fuzhou, 350005, China; Department of Gastrointestinal Surgery, National Regional Medical Center, Binhai Campus of th…

Zitieren

APA

Lin, P., Lin, C., Lin, Y., Liu, S., Ruan, F., Lin, Y., Zhang, S., Liu, Z., Li, W., Li, J., Ye, J., & Zhu, G. (2027). TIMP1 and CLDN23 may contribute to adenoma-to-colorectal cancer progression and nominate ruxolitinib for repurposing. Translational Oncology, 75, 103116. https://doi.org/10.1016/j.tranon.2026.103116

Vancouver

Lin P, Lin C, Lin Y, Liu S, Ruan F, Lin Y, et al. TIMP1 and CLDN23 may contribute to adenoma-to-colorectal cancer progression and nominate ruxolitinib for repurposing. Translational Oncology. 2027;75:103116. doi:10.1016/j.tranon.2026.103116

BibTeX
@article{Lin2027,
  author = {Lin, Penghang and Lin, Chunlin and Lin, Yuexin and Liu, Songyi and Ruan, Fangqiu and Lin, Yan and Zhang, Shuyuan and Liu, Zhixiong and Li, Weilong and Li, Jie and Ye, Jianxin and Zhu, Guangwei},
  title = {TIMP1 and CLDN23 may contribute to adenoma-to-colorectal cancer progression and nominate ruxolitinib for repurposing},
  journal = {Translational Oncology},
  year = {2027},
  volume = {75},
  pages = {103116},
  doi = {10.1016/j.tranon.2026.103116}
}
Kostenlos starten →